Oncology Platform
GemPharmatech has successfully developed multiple PDX models, which cover cancers such as gastrointestinal, liver, pancreatic, lung, and hematologic, for a wide variety of uses, including efficacy evaluations, clinical studies as treatment control, and pathogenesis studies.